Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine

Name: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine
License: Public Domain

Novartis Vaccines

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

meningococcal disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 356525
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.